Availability

Bedrocan currently produces medicinal cannabis API and raw materials for pharmaceutical distributors and pharmaceutical manufacturers worldwide. Our products are also dispensed for patient use (under the care of a physician), through medicinal cannabis compassionate programmes, such as in the Netherlands.  Medicinal cannabis products prepared from Bedrocan’s cannabis materials are available in different jurisdictions. Below, you can find the availability per country.

Note to patients

You cannot order medicinal cannabis at Bedrocan. Bedrocan’s products can only be ordered by pharmaceutical distributors, wholesalers and pharmaceutical manufacturers. The final products are dispensed by pharmacies and are available exclusively on prescription. Provided that your government issues medicinal cannabis in your country, your GP or treating specialist can prescribe Bedrocan’s medicinal cannabis, and you can take the prescription to your local pharmacy.

Medicinal cannabis availability inside the EU?

There is a possibility to collect Bedrocan products in the Netherlands with a valid prescription from a medical doctor practising in the EU. Before providing the prescription in a Dutch pharmacy, it is advisable to check whether the pharmacy has medicinal cannabis available.

Please contact the authorities in your country to verify the possibility of bringing medicinal cannabis products from the Netherlands with you. In most cases, an import permit is needed.

Other regulatory approaches

Cannabis and cannabis products are unauthorised pharmaceuticals. According to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA),  many European countries have some type of compassionate access programme for unauthorised pharmaceuticals. These are known by various names depending on the country, such as early-access programmes, special access programmes, named patient programmes and managed access programmes. Under these schemes, access to unapproved medicines usually requires a prescription by a licensed medical practitioner and approval by the pharmaceutical regulator for the patient to obtain and use the medicine.
There is a wide variation in how these programmes are implemented at a national level, and each country has its own rules and procedures for allowing cannabis preparations to be provided to patients.

Source: European Monitoring Centre for Drugs and Drug Addiction (2018), Medical use of cannabis and cannabinoids: questions and answers for policymaking, Publications Office of the European Union, Luxembourg.

Medicinal cannabis availability outside the EU

Please contact your local authorities first to find out if they allow import.